Related references
Note: Only part of the references are listed.Inositol hexaphosphate suppresses colorectal cancer cell proliferation via the Akt/GSK-3β/β-catenin signaling cascade in a 1,2-dimethylhydrazine-induced rat model
Wenyang Yu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Association of PI3K/AKT/mTOR pathway genetic variants with type 2 diabetes mellitus in Chinese
Yin Xueyao et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
S6Ks isoforms contribute to viability, migration, docetaxel resistance and tumor formation of prostate cancer cells
Camila L. Amaral et al.
BMC CANCER (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement
Simona Dinicola et al.
EXPERIMENTAL CELL RESEARCH (2016)
Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study
Pedro-Antonio Regidor et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2016)
Role of phytochemicals in colorectal cancer prevention
Yu-Hua Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Expression and clinical significance of mammalian target of rapamycin/P70 ribosomal protein S6 kinase signaling pathway in human colorectal carcinoma tissue
Qingjun Lu et al.
ONCOLOGY LETTERS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Mollugin induces tumor cell apoptosis and autophagy via the PI3K/AKT/mTOR/p70S6K and ERK signaling pathways
Li Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
A growing role for mTOR in promoting anabolic metabolism
Jessica J. Howell et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Chemoprevention of Gastrointestinal Cancer: The Reality and the Dream
Kyung-Soo Chun et al.
GUT AND LIVER (2013)
Pro-Apoptotic Effect of Rice Bran Inositol Hexaphosphate (IP6) on HT-29 Colorectal Cancer Cells
Nurul Husna Shafie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
Brian Magnuson et al.
BIOCHEMICAL JOURNAL (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
mTOR Kinase Domain Phosphorylation Promotes mTORC1 Signaling, Cell Growth, and Cell Cycle Progression
Bilgen Ekim et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-κB
Parvaneh Rafiee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
Sara M. Johnson et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Phytochemicals in Cancer Prevention and Therapy: Truth or Dare?
Maria Russo et al.
TOXINS (2010)
The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
Alberto M. Martelli et al.
Cancers (2010)
p21/Cip1 and p27/Kip1 Are Essential Molecular Targets of Inositol Hexaphosphate for Its Antitumor Efficacy against Prostate Cancer
Srirupa Roy et al.
CANCER RESEARCH (2009)
Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target
Mallikarjuna Gu et al.
CANCER RESEARCH (2009)
Molecular mechanisms of mTOR-mediated translational control
Xiaoju Max Ma et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Is Akt the Warburg kinase?-Akt-energy metabolism interactions and oncogenesis
R. Brooks Robey et al.
SEMINARS IN CANCER BIOLOGY (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
Preetha Anand et al.
PHARMACEUTICAL RESEARCH (2008)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line
Ying Tian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma
Irfan Rizvi et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Protection against cancer by dietary IP6 and inositol
Ivana Vucenik et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects
T Maffucci et al.
CANCER RESEARCH (2005)
Inositol hexaphosphate-induced enhancement of natural killer cell activity correlates with suppression of colon carcinogenesis in rats
Zheng Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Increased levels of inositol hexakisphosphate (InsP6) protect HEK293 cells from tumor necrosis factor α- and Fas-induced apoptosis
J Verbsky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inositol hexaphosphate (IP6): A novel treatment for pancreatic cancer
P Somasundar et al.
JOURNAL OF SURGICAL RESEARCH (2005)
Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCδ-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation
I Vucenik et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The activation of Akt/PKB signaling pathway and cell survival
G Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Inositol pentakisphosphate promotes apoptosis through the PI3-K/Akt pathway
E Piccolo et al.
ONCOGENE (2004)
Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells
C Agarwal et al.
NEOPLASIA (2004)
Anti-angiogenic activity of inositol hexaphosphate (IP6)
I Vucenik et al.
CARCINOGENESIS (2004)
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
RP Singh et al.
CARCINOGENESIS (2003)
Cancer inhibition by inositol hexaphosphate (IP6) and inositol: From laboratory to clinic
I Vucenik et al.
JOURNAL OF NUTRITION (2003)
Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFκB-mediated cell survival pathway
S Ferry et al.
CARCINOGENESIS (2002)
Fruit, vegetables, dietary fiber, and risk of colorectal cancer
P Terry et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis
EA Slee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells
XL Zi et al.
CARCINOGENESIS (2000)
Share Paper
